Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases.
IPO Date: November 9, 1984
Sector: Healthcare
Industry: Biotech
Market Cap: $313.08M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.19 | 3.64%
Avg Daily Range (30 D): $0.25 | 4.38%
Avg Daily Range (90 D): $0.18 | 3.27%
Institutional Daily Volume
Avg Daily Volume: .75M
Avg Daily Volume (30 D): 2.4M
Avg Daily Volume (90 D): 1.12M
Trade Size
Avg Trade Size (Sh.): 230
Avg Trade Size (Sh.) (30 D): 144
Avg Trade Size (Sh.) (90 D): 136
Institutional Trades
Total Inst.Trades: 372
Avg Inst. Trade: $1.4M
Avg Inst. Trade (30 D): $.9M
Avg Inst. Trade (90 D): $.88M
Avg Inst. Trade Volume: .03M
Avg Inst. Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.68M
Avg Closing Trade (30 D): $.97M
Avg Closing Trade (90 D): $.97M
Avg Closing Volume: 19.56K
       
News
May 14, 2025 @ 5:57 PM
US FDA Orphan Drug Rare Disease Market Clinical Tr...
Source: Kuick Research
Apr 29, 2025 @ 10:00 AM
U.S. FDA Approves ZEVASKYNâ„¢ (prademagene zam...
Source: Abeona Therapeutics Inc.
Feb 21, 2025 @ 6:00 PM
Cell and Gene Therapies in Rare Disorders Market t...
Source: Delveinsight
Jan 2, 2025 @ 7:30 AM
Global Mucopolysaccharidosis Treatment Market to W...
Source: Sabyasachi Ghosh (Associate Vice President At Future Market Insights, Inc.)
Jun 3, 2024 @ 11:30 AM
Abeona Therapeutics Announces New Employee Inducem...
Source: Abeona Therapeutics Inc.
Financials
  TTM Q4 2024 FY 2024
Basic EPS $-.24 $-.14 $-1.55
Diluted EPS $-.24 $-.14 $-1.55
Revenue $ M $ M $ M
Gross Profit $ $ $
Net Income / Loss $ -12.03M $ -9.29M $ -63.73M
Operating Income / Loss $ -19.73M $ -16.67M $ -64.21M
Cost of Revenue $ $ $
Net Cash Flow $ -7.42M $ 7.63M $ 8.88M
PE Ratio    
Splits
Jul 05, 2022:   1:25
Oct 24, 2014:   1:50
Jun 05, 2006:   1:5